about
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the fiel...
Read More
59.26
1.29
(2.23%)
716.7K
XNAS Volume
XNAS 11 Nov, 2025 4:30 PM (EST)
Board Meeting
The next board meeting for Nektar Therapeutics is on 20 Nov 2025 for the purpose of Jefferies Global Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Bullish
Nektar Therapeutics Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..